Literature DB >> 28189538

Loperamide misuse and abuse.

Heather Miller, Ladan Panahi, Daniel Tapia, Andrew Tran, John D Bowman.   

Abstract

OBJECTIVE: The epidemic of opioid prescription deaths in recent years resulted in the recent rescheduling of hydrocodone-containing products to restrict access to them. Opioid users have recognized that loperamide can ameliorate withdrawal symptoms and also produce euphoria in very high doses. This article discusses the potential for loperamide misuse and abuse and examines trends in the increasing number of published cases of loperamide toxicity.
DESIGN: PubMed was used to search MEDLINE for case reports of loperamide abuse.
SETTING: United States. MAIN OUTCOME MEASURES: Numbers of cases of loperamide misuse, characteristics of patients, reported toxicities.
RESULTS: From 1985 to 2016, 54 case reports of loperamide toxicity were published, with 21 cases between 1985 and 2013 and 33 cases between 2014 and 2016. In addition, 179 cases of intentional loperamide misuse were reported to the National Poison Database System between 2008 and 2016, with more than half reported after January 1, 2014.
CONCLUSION: Loperamide misuse and abuse is increasing in the United States, and pharmacists are encouraged to monitor and restrict their sales.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28189538     DOI: 10.1016/j.japh.2016.12.079

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  12 in total

1.  Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2.

Authors:  Yun-Qing Song; Rong-Jing He; Dan Pu; Xiao-Qing Guan; Jin-Hui Shi; Yao-Guang Li; Jie Hou; Shou-Ning Jia; Wei-Wei Qin; Sheng-Quan Fang; Guang-Bo Ge
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

2.  The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

Authors:  Julien C Dodu; Rebecca K Moncayo; M Imad Damaj; Joel E Schlosburg; Hamid I Akbarali; Lesley D O'Brien; Debra A Kendall; Zhixing Wu; Dai Lu; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2021-10-08       Impact factor: 4.402

Review 3.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

4.  A commentary on operamide and cardiotoxicity.

Authors:  Salil R Rajayer; Charanya Sivaramakrishnan
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-09-19

5.  Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro.

Authors:  Qian-Meng Lin; Ying-Hui Li; Qian Liu; Ni-Hong Pang; Ren-Ai Xu; Jian-Ping Cai; Guo-Xin Hu
Journal:  Infect Drug Resist       Date:  2019-09-10       Impact factor: 4.003

6.  Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report.

Authors:  Jonathan D Cicci; Sarah M Jagielski; Megan M Clarke; Robert A Rayson; Matthew A Cavender
Journal:  Eur Heart J Case Rep       Date:  2019-09-27

Review 7.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22

8.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

9.  Cardiac Arrhythmia Secondary to Loperamide Abuse and Toxicity.

Authors:  Mohammed Ali; Aisha Mujahid; Chinthaka P Bulathsinghala; Salim Surani
Journal:  Cureus       Date:  2020-02-10

Review 10.  Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.

Authors:  Łukasz Sobczak; Krzysztof Goryński
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.